News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
NEJM Reports Phase 3 Trial on Omitting Nodal Irradiation in Node-Positive Breast Cancer
Photo: Depositphotos
Jun 6, 2025, 12:16

NEJM Reports Phase 3 Trial on Omitting Nodal Irradiation in Node-Positive Breast Cancer

NEJM shared a post on X:

“In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiation did not reduce breast cancer recurrence or improve survival.

Full results from a phase 3 trial.”

NEJM Reports Phase 3 Trial on Omitting Nodal Irradiation in Node-Positive Breast Cancer

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.

Authors: Eleftherios P. Mamounas, Hanna Bandos, Julia R. White, Thomas B. Julian, Atif J. Khan, Simona F. Shaitelman, Mylin A. Torres, Frank A. Vicini, Patricia A. Ganz, Susan A. McCloskey, Peter C. Lucas, Nilendu Gupta, X. Allen Li, Beryl McCormick, Benjamin Smith, Rahul D. Tendulkar, Vivek S. Kavadi, Koji Matsumoto, Samantha Andrews Seaward, William J. Irvin, Jr., Jolinta Y. Lin, Robert W. Mutter, Thierry M. Muanza, Jannifer Stromberg, Reshma Jagsi, Anna C. Weiss, Walter J. Curran, Jr., and Norman Wolmark.

You can read the full article on The New England Journal of Medicine.

NEJM Reports Phase 3 Trial on Omitting Nodal Irradiation in Node-Positive Breast Cancer

More posts featuring NEJM.

Anna C. Weiss Atif J Khan Benjamin Smith Beryl McCormick Breast Cancer cancer Eleftherios P. Mamounas fight against cancer Frank A. Vicini Global fight against cancer Hanna Bandos Jannifer Stromberg Jolinta Y. Lin Jr. Julia R. White Koji Matsumoto Mylin A. Torres NEJM neoadjuvant chemotherapy neoadjuvant therapy Nilendu Gupta Nodal Irradiation Norman Wolmark OncoDaily Oncology Patricia A. Ganz Peter C. Lucas Rahul D. Tendulkar Reshma Jagsi Robert W. Mutter Samantha Andrews Seaward Simona F Shaitelman Susan A. McCloskey The New England Journal of Medicine. Thierry M. Muanza Thomas B. Julian Vivek S. Kavadi Walter J. Curran William J. Irvin X. Allen Li
Special Coverage
Voices
Aug 10, 2025, 15:36
Wafaa M Rashed: Africa for Africans - Shaping the Future of Genomics Policy
Career
Aug 10, 2025, 15:36
Bogda Koczwara: Join the Team of Australian Research Centre for Cancer Survivorship
Voices
Aug 10, 2025, 15:26
Sendurai Mani: Joining the Partnership to Reduce Cancer in Rhode Island Membership Meeting
Career
Aug 10, 2025, 15:00
Santosh Rao Joined to the HemOnc Department at Cleveland Clinic Akron General as the Medical Director
Science
Aug 10, 2025, 14:54
Monika J Dziuba: The Role of Organoids in Precision Medicine
Voices
Aug 10, 2025, 14:50
The Future of Pharmaceutical Infrastructure and Equitable Access to Medicines - Hikma Pharmaceuticals
Voices
Aug 10, 2025, 14:31
Anju Aledia: Celebrating Strength, Unity, and Hope Among Children Fighting Cancer
Voices
Aug 10, 2025, 14:19
Harish Nagaraj: Advancing Neuroendocrine Tumor Care in East and Sub-Saharan Africa
Opinion
Aug 10, 2025, 13:44
Olivier Elemento: Accelerating Innovation with Safe and Effective Guardrails
Voices
Aug 10, 2025, 13:01
Olubukola Ayodele: Breast Cancer Subtypes and What They Mean for Patients and Treatment
Voices
Aug 10, 2025, 12:49
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute Has Launched First-in-Human Phase 1A Clinical Trial
Blog
Aug 10, 2025, 12:46
Ashwin Mallya: Bladder Cancer Care is No Longer a Solo Act